Proteintech announced the acquisition of ChromoTek


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Proteintech announced the acquisition of ChromoTek
The merger will enable the two companies to take full advantage of growing industry opportunities and more effectively address industry challenges

Proteintech, the reference standard for antibodies, announced the acquisition of ChromoTek, a manufacturer of single domain camelid antibodies, also known as nanoantibodies.

ChromoTek is the industry leader in nanoantibodies, high-throughput recombinant reagents used in research activities leading to groundbreaking discoveries. The merger will enable the two companies to take full advantage of growing industry opportunities and more effectively address industry challenges in single cell analysis, super resolution imaging and multiplexing assays.

"Our specialized nanoantibody-based tools seamlessly integrate with Proteintech's comprehensive antibody portfolio that covers a large part of the proteome," says Dr Marion Jung, CEO of ChromoTek. "It is exciting to collaborate with a company that shares our values ​​in terms of reproducibility and quality for the benefit of research and beyond," he adds.

Proteintech CEO Dr Jason Li commented: "This new collaboration will generate considerable value for the market. The availability of manufacturing facilities on three different continents will allow us to better meet the needs of the research market and will have a profound impact on translational science and therapeutic applications ".

Founded in 2002, Proteintech is a leading manufacturer of antibodies, proteins and immunoassays. The company has the largest unique portfolio of self-made antibodies that cover two-thirds of the human proteome. With more than 70,000 publications and a proven specificity, Proteintech offers antibodies and immunoassays for all areas of research. Additionally, Proteintech produces cytokines, growth factors, and other human-expressed proteins that are bioactive and meet current GMP standards. 

ChromoTek is a pioneer in the development and commercialization of innovative reagents based on camelid nanoantibodies. Unlike traditional antibodies, nanoantibodies consist of a single polypeptide chain and are the smallest known antibodies. The company has unique expertise in developing nanoantibodies with the desired affinity, specificity, and format for applications in biomedical research areas where other antibody formats do not work. As the market and product leader in high-throughput reagents, we are proud to contribute to groundbreaking research discoveries around the world. 

Tags : #Proteintech #LatestNewsonProteintech22ndOct #ChromoTek #LatestNewsonChromoTek22ndOct #LatestPharmaNews22ndOct #LatestPharmaAcquisitionNews22ndOct #DrMarionJung #DrJasonLi

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Reforming global financial architecture is critical for gender equality and right to healthJuly 14, 2025
Francesco Arezzo takes office as president of Rotary InternationalJuly 14, 2025
CBM India Highlights Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA 19th Annual ConferenceJuly 14, 2025
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy’July 14, 2025
NMC Notifies Medical Institutions (Qualifications of Faculty) Regulations, 2025 to Expand Medical Education Capacity and Strengthen Faculty Availability July 14, 2025
India’s Roads, India’s Pain: Healing Beyond the HospitalJuly 14, 2025
When Weathers Go Deadly: Role Of Climate Change In Stimulating The Proliferation Of Disease-carrying VectorsJuly 14, 2025
India’s Hidden Health Emergency: Climate Pressures on WellbeingJuly 14, 2025
The Silent Urgency: Why Geriatric Health Homes Can’t Wait AnymoreJuly 14, 2025
Rewiring the Brain: How Neuroscience Apps Are Changing Stroke RecoveryJuly 14, 2025
Healing Happens at Home: How Community Care Breaks the Cycle of Repeat Hospital TripsJuly 14, 2025
The Future Is Hands-On: How AR Is Quietly Reshaping Physical TherapyJuly 14, 2025
Flying Lifelines: Why Medical Drones are Changing Supply Chains in SilenceJuly 14, 2025
The Silent Hunger Are Well Fed Indian Teens Actually MalnourishedJuly 14, 2025
Richest 1% people have enough new wealth to end annual poverty 22 times overJuly 11, 2025
Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India’s Food Fortification LandscapeJuly 11, 2025
Sarvodaya Hospital, Greater Noida West, Launches Next-Gen Fully Active Robotic System for Joint ReplacementJuly 10, 2025
Children Dazzle the Stage at Faridabad Talent Hunt at Asian Institute of Medical SciencesJuly 10, 2025
From Macro to Mandate: How India's Affluent Investors are Positioning for Global ShiftsJuly 10, 2025
Actress-turned-Entrepreneur raises alarm over hidden pet health crisis in IndiaJuly 10, 2025